Americord is one of the companies reviewed in many categories in this article<\/a> that you should read before any decision to find out which is the best cord blood bank<\/a> for you.<\/p>\n Americord is currently a leading company<\/a> with regards to an innovative approach to cord blood, cord tissue<\/a>, and placenta tissue banking<\/a>.\u00a0 The innovative solutions allow Americord to collect twice as many stem cells<\/a> in a sample when compared to the industry standard.<\/p>\n According to their own claims, this revolutionary technology enables Americord to store and preserve twice the number of stem cells<\/a> when compared with an industry standard.\u00a0 The current industry standard is 60 milliliters of cord blood tissue per unit.\u00a0 Cord Blood 2.0 technology allows 150 milliliters to be collected in a single sample.\u00a0 This technique from Americord has solved one of the major setbacks of cord blood banking.\u00a0 The standard industry sample size was sufficient to treat a patient weighing up to 65lb.\u00a0 With Cord Blood 2.0 being available, larger patients weighing up to 165 lb are also eligible for treatment.\u00a0 Additionally, this technology enables the children to be treated with autologous stem cell transplantation<\/a> not only during the early childhood but also during adolescence and early adulthood.<\/p>\n Cord tissue stem cells differ from those isolated from cord blood<\/a>.\u00a0 Stem cells originating from cord tissue<\/a> are the so-called mesenchymal stem cells.\u00a0 Their main characteristic is that they are multipotent i.e. they can differentiate into multiple cell types.\u00a0 A plenty of research is currently underway, with the main objective to explore the multiple possibilities of use of this type of cells<\/a> in the management of Alzheimer\u2019s disease, spinal cord injuries, diabetes and many other serious chronic conditions.\u00a0 Banking of mesenchymal stem cells<\/a>, also a practice from Americord,\u00a0 opens a whole new world of possibilities and offers a wide range of options in the treatment of heart diseases, metabolic disturbances, injuries or even cancer. No doubt of the importance of cord blood banking<\/a> with so many new opportunities of utilization<\/a> nowadays.<\/p>\n The placenta contains mesenchymal stem cells (MSCs) that belong to the mother.\u00a0 These cells are responsible for placental growth and differentiation during pregnancy.\u00a0 MSCs isolated from placenta have a potential to differentiate into a wide range of mature cells.\u00a0 These cells represent a compatible match to the mother, which enables mothers to be treated with this precious resource.\u00a0 Banking of MSCs allows mothers to have an access to a source of renewable cells used in antiaging therapy, regenerative medicine and other fields of use of innovative stem cell technologies to treat various conditions related to immune system disorders or neurological disorders.\u00a0 It has been demonstrated that these cells are well tolerated by the host.\u00a0 They may produce immunomodulatory molecules such as cytokines and therefore modify the host\u2019s immune response, ensuring that they will not be rejected after transplantation.<\/p>\n Americord offers a collection kit<\/a> that is specifically designed to provide the maximum flexibility and the best care to the parents and healthcare professionals.\u00a0 Americord , registered with the AABB,<\/a> uses the only FDA approved sterile exterior collection bag that is ready to use for both the vaginal and C-section types of delivery.\u00a0 The collection kit contains all the equipment pertinent to the collection of samples.\u00a0 Regardless of the parents’ decision what to bank, Americord collection kit<\/a> always has the equipment required to collect all 3 sources of stem cells originating from cord blood, cord tissue or placenta.\u00a0 Each collection kit contains the informed consent along with the instructions for use that are user-friendly.\u00a0 If the parents decide to bank only cord blood, but later on choose to store other tissues such as cord tissue or placenta, they will still use the same kit.\u00a0 If the parents give up banking at the last minute, Americord did not charge any cancellation fees in the past, something that adds to the analysis of the\u00a0costs of cord blood banking<\/a> and will help you to decide if you will donate cord blood<\/a> to a public cord blood bank<\/a>\u00a0like Carolina,<\/a> or instead go to a private cord blood bank like this one<\/a>. Check the current agreements with Americord, and also with their competitors<\/a> such as Viacord<\/a> and CBR<\/a> if they offer you the same advantages.<\/p>\n Americord offers an innovative and easy-to-use e-commerce website that allows the parents to order and purchase the services online in a simple and comprehensive manner.\u00a0 Their website<\/a> offers expecting parents to get the necessary information regarding cord blood, cord tissue and placenta tissue<\/a> banking in order to make the best possible decision for the future<\/a>.\u00a0 Subscription and purchase process is as easy and user-friendly as for any other online service.<\/p>\n Americord operates by implementing the highest standards within the industry of stem cells preservation.\u00a0 In the past, the failure of stem cells to engraft was covered by the insurance fee. Check if Americord is currently offering this insurance. Our finding is that they are not covering this insurance, as other companies<\/a> are doing. The fee is sufficient to cover the expenses related to the acquisition of alternative sources of stem cells if there is a medical need.<\/p>\n Americord has been licensed by the US FDA<\/a> for banking of cord blood, cord tissue and placenta tissue.\u00a0 It is one of the few banks<\/a> in the United States to obtain registration for banking of placenta tissue.\u00a0 Following collection and processing, parents are provided with the certificate containing information regarding the number of harvested cells as well as the quality of the sample.\u00a0 Americord does not charge any services related to the release of stem cells for therapeutic purposes.\u00a0 The company’s central laboratory is registered by the US FDA and accredited by AABB.<\/a>\u00a0 This lab also functions as a public bank<\/a> for storage of samples used for bone marrow and\/or hematopoietic stem cell transplantation.\u00a0 Americord actively supports investigations related to the therapeutic use of stem cells originating from cord blood, cord or placenta tissue.\u00a0 Americord has released three units of cord blood that were used successfully during autologous transplantation procedure.\u00a0 Several studies funded by Americord are underway to investigate the most effective methods for obtaining the highest possible number of stem cells from the placenta.<\/p>\n There are other investigations in Americord, one of the current goals of treating HIV\/AIDS is to provide a unique and effective treatment modality that will induce a life-long remission of HIV with less discomfort caused by serious side effects of the current treatment.\u00a0 Hematopoietic stem cells that are genetically modified to be HIV resistant could provide a cure for HIV\/AIDS with a single treatment.\u00a0 Specifically designed hematopoietic stem cells containing anti-HIV genes are capable of self-renewal and may provide long-term remission of HIV patient during the lifetime.\u00a0 A significant number of clinical trials are currently underway to investigate this precious potential of hematopoietic stem cells.<\/p>\n <\/p>\n","protected":false},"excerpt":{"rendered":" About Americord This cord blood banking company, Americord Registry LLC, provides services of cord blood banking and cord tissue as well as banking of tissue of the placenta.\u00a0 The company Americord was founded in 2008 and is based in New York.\u00a0 For the period of ten years, the company strives to provide the most technologically…<\/p>\n","protected":false},"author":1,"featured_media":409,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_kad_post_transparent":"","_kad_post_title":"","_kad_post_layout":"","_kad_post_sidebar_id":"","_kad_post_content_style":"","_kad_post_vertical_padding":"","_kad_post_feature":"","_kad_post_feature_position":"","_kad_post_header":false,"_kad_post_footer":false,"footnotes":""},"categories":[15],"tags":[],"_links":{"self":[{"href":"https:\/\/imedicalsociety.org\/wp-json\/wp\/v2\/posts\/610"}],"collection":[{"href":"https:\/\/imedicalsociety.org\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/imedicalsociety.org\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/imedicalsociety.org\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/imedicalsociety.org\/wp-json\/wp\/v2\/comments?post=610"}],"version-history":[{"count":0,"href":"https:\/\/imedicalsociety.org\/wp-json\/wp\/v2\/posts\/610\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/imedicalsociety.org\/wp-json\/wp\/v2\/media\/409"}],"wp:attachment":[{"href":"https:\/\/imedicalsociety.org\/wp-json\/wp\/v2\/media?parent=610"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/imedicalsociety.org\/wp-json\/wp\/v2\/categories?post=610"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/imedicalsociety.org\/wp-json\/wp\/v2\/tags?post=610"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}![](\"https:\/\/imedicalsociety.org\/wp-content\/uploads\/2020\/11\/2.jpg\")
Cord Blood 2.0<\/h2>\n
Cord Tissue Sampling<\/h2>\n
Placenta Tissue Banking<\/h2>\n
Collection Kit<\/h1>\n
Online Banking<\/h1>\n
Insurance In Americord<\/h1>\n
Other Benefits Claimed by Americord<\/h1>\n